| Indian Health Service | |
|
3883 74th Ave. Ne Fort Totten ND 58335-0309 | |
| (701) 766-7600 | |
| (701) 766-1630 |
| Full Name | Indian Health Service |
|---|---|
| Speciality | Clinic/center - Public Health, Federal |
| Location | 3883 74th Ave. Ne, Fort Totten, North Dakota |
| Authorized Official Name and Position | Darren C Martell (ACTING CEO) |
| Authorized Official Contact | 7017661600 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Indian Health Service Po Box 309 3883 74th Ave. Ne Fort Totten ND 58335-0309 Ph: (701) 766-7600 | Indian Health Service 3883 74th Ave. Ne Fort Totten ND 58335-0309 Ph: (701) 766-7600 |
| NPI Number | 1972535433 |
|---|---|
| Provider Enumeration Date | 07/07/2006 |
| Last Update Date | 02/23/2009 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972535433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP0904X | Clinic/center - Public Health, Federal | (* (Not Available)) | Primary |
News Archive
Micell Technologies,™ Inc. today announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries), a first-in-human clinical trial of the company's investigational MiStent™ Drug Eluting Coronary Stent System (MiStent DES).
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to ravage the world, scientists are frantically searching for a vaccine or new drug that will effectively counter the lethal effects of the virus that leads to COVID-19 disease.
Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.
Swapping a single amino acid in a simple bacterial protein changes its structure and function, revealing the effects of complex gene evolution, finds a new study published in the journal eLife.
CVS Health and Adapt Pharma today announced a new partnership that will make the opioid overdose-reversing drug NARCAN (Naloxone HCl) Nasal Spray more affordable for patients without insurance at CVS Pharmacy locations.
› Verified 8 days ago
Spirit Lake Health Center Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 Fax: 701-766-1630 | |
Public Health Nursing Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 816 3rd Ave N, Fort Totten, ND 58335 Phone: 701-766-4236 Fax: 701-766-4878 |